| Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution E Mamcarz, R Madden, A Qudeimat, A Srinivasan, A Talleur, A Sharma, ... Bone marrow transplantation 55 (5), 929-938, 2020 | 36 | 2020 |
| Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL AC Talleur, A Qudeimat, JY Métais, D Langfitt, E Mamcarz, JC Crawford, ... Blood Advances 6 (21), 5737-5749, 2022 | 22 | 2022 |
| Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host T Flerlage, JN Brazelton de Cardenas, CD Garner, NA Hasan, H Karathia, ... Open forum infectious diseases 7 (2), ofaa018, 2020 | 12 | 2020 |
| Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS A Sharma, Y Li, S Huang, AC Talleur, A Suliman, A Qudeimat, ... Bone Marrow Transplantation 56 (8), 1866-1875, 2021 | 10 | 2021 |
| Case report: management approach and use of extracorporeal membrane oxygenation for diffuse alveolar hemorrhage after pediatric hematopoietic cell transplant K Fan, C Hurley, MJ McNeil, A Agulnik, S Federico, A Qudeimat, A Saini, ... Frontiers in Pediatrics 8, 587601, 2021 | 7 | 2021 |
| Pulmonary complications in children following hematopoietic cell transplantation: a case report and review of the diagnostic approach L Elbahlawan, J McArthur, CE Morin, H Abdelhafeez, MB McCarville, ... Frontiers in oncology 11, 772411, 2021 | 6 | 2021 |
| Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML T Pfeiffer, Y Li, E Ashcraft, SE Karol, JE Rubnitz, R Epperly, R Madden, ... Bone Marrow Transplantation 58 (3), 328-331, 2023 | 5 | 2023 |
| Bioactive sphingolipids in neuroblastoma M Rahmaniyan, A Qudeimat, JM Kraveka Neuroblastoma-Present and Future, 153-184, 2012 | 5 | 2012 |
| Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience AC Talleur, RM Madden, A Qudeimat, E Mamcarz, A Sharma, ... Blood 136, 39-40, 2020 | 4 | 2020 |
| CD45RA-depleted haploidentical transplantation combined with NK cell addback results in promising long-term outcomes in pediatric patients with high-risk hematologic malignancies S Naik, AC Talleur, Y Li, RM Madden, E Mamcarz, A Qudeimat, A Sharma, ... Blood 138, 172, 2021 | 3 | 2021 |
| Haploidentical CD45RA-Negative Donor Lymphocyte Infusions Are Feasible, Safe and Associated with Clinical Benefit AC Talleur, Y Li, S Akel, A Sharma, A Qudeimat, A Srinivasan, E Mamcarz, ... Biology of Blood and Marrow Transplantation 26 (3), S268, 2020 | 3 | 2020 |
| Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients R Epperly, AC Talleur, Y Li, S Schell, MC Tuggle, JY Métais, S Huang, ... Transplantation and cellular therapy 28 (5), 262. e1-262. e10, 2022 | 2 | 2022 |
| CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia S Naik, RM Madden, E Mamcarz, A Srinivasan, A Sharma, AC Talleur, ... Blood 138, 2897, 2021 | 2 | 2021 |
| Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML. T Pfeiffer, Y Li, SE Karol, JE Rubnitz, R Epperly, R Madden, E Mamcarz, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | 1 | 2022 |
| Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial M Kjellin, A Qudeimat, E Browne, D Keerthi, A Sunkara, G Kang, ... Journal of Pediatric Oncology Nursing 37 (6), 390-397, 2020 | 1 | 2020 |
| Autologous CD19-CAR T-cells for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients: an initial report from an institutional phase I/II study A Talleur, A Qudeimat, T Lockey, A Gaboriault, D Langfitt, JY Metais, ... Clinical Lymphoma, Myeloma and Leukemia 19, S265, 2019 | 1 | 2019 |
| Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell dose for peripheral blood allogeneic hematopoietic cell transplantation in children JR Wells, A Sunkara, G Kang, J Hale, C Hughes, L Alloush, R Madden, ... Biology of Blood and Marrow Transplantation 24 (3), S423-S424, 2018 | 1 | 2018 |
| Disease Status and Interval between HCTs Predict Outcome of Pediatric Patients who Undergo a Subsequent HCT for Relapsed Hematologic Malignancy R Epperly, Y Li, S Selukar, E Zeng, R Madden, E Mamcarz, S Naik, ... Transplantation and Cellular Therapy, 2024 | | 2024 |
| Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study S Suryaprakash, Y Bi, S Selukar, D Keerthi, A Qudeimat, AC Talleur, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Transplantation's Aftermath: Navigating the Landscape of Post-Hematopoietic Cellular Therapy Neoplasms R Rihani, K Halahleh, H Hashem, E Khattab, MA Shanap, I Sultan, ... Transplantation and Cellular Therapy 30 (2), S295, 2024 | | 2024 |
